Processa Pharmaceuticals, Inc. announced that its Board of Directors approved the appointment of Gregory J. Flesher as Chief Operating Officer, effective November 4, 2026. Under his employment letter, Mr. Flesher is entitled to an annual base salary of $700,000 and a discretionar